Anti-Human CD45 Monoclonal Antibodies in Patients With Advanced Leukemia Prior to Allogeneic Stem Cell Transplantation
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
Participants in this study have a hematologic malignancy which is a disorder in the bone
marrow that affects the body's ability to create blood. Participants might benefit from
receiving an allogeneic stem cell transplant (meaning the cells come from a donor). The
participants donor is a family member. Stem cells are cells in the bone marrow and blood that
can form a whole new blood system.
Phase:
Phase 1
Details
Lead Sponsor:
Baylor College of Medicine
Collaborators:
Center for Cell and Gene Therapy, Baylor College of Medicine Texas Children's Hospital The Methodist Hospital Research Institute The Methodist Hospital System